CTIC CTIC

CTI BioPharma Stock Price

5.77
0.13 (2.3%)
5.77
Volume 3,188,417
Bid Price 5.76
Ask Price 5.77
News -
Day High 5.78

Low
1.43

52 Week Range

High
7.80

Day Low 5.56
Company Name Stock Ticker Symbol Market Type
CTI BioPharma Corporation CTIC NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.13 2.3% 5.77 16:05:59
Open Price Low Price High Price Close Price Prev Close
5.73 5.56 5.78 5.76 5.64
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
15,560 3,188,417 $ 5.67 $ 18,085,411 - 1.43 - 7.80
Last Trade Time Type Quantity Stock Price Currency
16:23:58 formt 5,000 $ 5.77 USD

Period:

Draw Mode:

CTI BioPharma Corporation Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 660.00M 114.39M 105.23M $ - $ - -1.09 -4.70
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - -516.35k 6.50%

more financials information »

CTI BioPharma News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical CTIC Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week5.685.8955.335.683,849,6680.091.58%
1 Month6.046.715.336.043,875,102-0.27-4.47%
3 Months6.017.805.266.254,397,235-0.24-3.99%
6 Months5.187.803.325.714,432,7160.5911.39%
1 Year3.037.801.434.573,853,7162.7490.43%
3 Years0.897.800.623.841,904,8224.88548.31%
5 Years3.197.800.60013.701,275,7872.5880.88%

CTI BioPharma Description

CTI BioPharma Corp is a biopharmaceutical company focused on the acquisition, development, and commercialization of less toxic and more effective cancer therapies. Its therapeutic area is blood-related cancers. Its products under pipeline include PIXUVRI, and Pacritinib. PIXUVRI is a novel aza-anthracenedione with unique structural and physiochemical properties. Pacritinib is an investigational oral kinase inhibitor for the treatment of adult patients with myelofibrosis.


Your Recent History
NASDAQ
CTIC
CTI BioPha..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now